Full text is available at the source.
Abstract
Approximately 3700 patients with type 2 diabetes were included in a study investigating cardiovascular disease risk in the Middle East and Africa.
- The study aims to determine the prevalence of established atherosclerotic cardiovascular disease (eASCVD) and high/very high cardiovascular disease risk among patients with type 2 diabetes.
- It will assess the current use of cardioprotective antidiabetic medications in this patient population.
- The proportion of patients who meet treatment criteria for reimbursement will be evaluated in countries with applicable guidelines.
- Physician-reported factors influencing clinical decision-making in managing type 2 diabetes will also be explored.
Simplified